We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Oxford⁠–AstraZeneca Vaccine Is Safe and Highly Effective, Phase III Study Finds

News   Mar 22, 2021 | Original story from the University of Oxford

 
Oxford⁠–AstraZeneca Vaccine Is Safe and Highly Effective, Phase III Study Finds
 
 
Advertisement
 

RELATED ARTICLES

Probiotic Yeast Engineered To Produce Beta-Carotene

News

In order to produce beta-carotene in the guts of laboratory mice, researchers have genetically engineered a probiotic yeast. The advance demonstrates the utility of work the researchers have done to detail how a suite of genetic engineering tools can be used to modify the yeast.

READ MORE

Insights Into Resistance to Immune Checkpoint Inhibitors in Lung Cancer

News

Yale researchers have used a novel mouse model of KRAS-driven lung cancer to explore what drives acquired resistance to immune checkpoint inhibitors.

READ MORE

New Test Accurately Measures HIV Reservoir

News

A new test that measures the quantity and quality of inactive HIV viruses in the genes of people living with HIV may eventually give researchers a better idea of what drugs work best at curing the disease.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE